Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-16 4:30 pm Sale |
2023-10-04 | 13D | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% |
-34,705 (-0.42%) |
Filing History |
| 2023-07-07 1:27 pm Sale |
2023-06-30 | 13G | Standard BioTools Inc. LAB |
PRIMECAP MANAGEMENT CO | 3,220,917 4.110% |
-1,395,756 (-30.23%) |
Filing History |
| 2023-07-03 5:17 pm Sale |
2023-07-03 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 7,797,454 9.900% |
-779,345 (-9.09%) |
Filing History |
| 2023-02-14 4:33 pm Sale |
2022-12-31 | 13G | Standard BioTools Inc. LAB |
North Sound Trading, LP | 2,396,400 3.000% |
-1,978,600 (-45.23%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,323,821 9.500% |
8,323,821 (New Position) |
Filing History |
| 2023-02-14 10:26 am Purchase |
2022-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,894,751 9.900% |
308,846 (+4.07%) |
Filing History |
| 2023-02-09 4:02 pm Sale |
2022-12-31 | 13G | Standard BioTools Inc. LAB |
PRIMECAP MANAGEMENT CO | 4,616,673 5.820% |
-476,730 (-9.36%) |
Filing History |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 3,955,968 4.990% |
88,297 (+2.28%) |
Filing History |
| 2022-12-30 5:10 pm Sale |
2022-12-29 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 8,576,799 10.800% |
-2,868,037 (-25.06%) |
Filing History |
| 2022-11-14 4:43 pm Unchanged |
2022-11-14 | 13G | Standard BioTools Inc. LAB |
RA Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-08-05 11:13 am Purchase |
2022-08-04 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 11,444,836 14.800% |
1,021,648 (+9.80%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
2,017,210 2.600% |
-4,234,020 (-67.73%) |
Filing History |
| 2022-06-07 10:31 am Purchase |
2022-06-03 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 10,423,188 13.500% |
938,350 (+9.89%) |
Filing History |
| 2022-05-03 12:40 pm Purchase |
2022-04-29 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 9,484,838 12.300% |
1,104,573 (+13.18%) |
Filing History |
| 2022-04-14 5:09 pm Purchase |
2022-04-04 | 13G | PROCEPT BioRobotics Corporation PRCT |
VIKING GLOBAL INVESTORS LP | 8,103,527 9.500% |
8,103,527 (New Position) |
Filing History |
| 2022-04-08 5:07 pm Purchase |
2022-04-04 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 37,582,346 32.740% |
37,582,346 (New Position) |
Filing History |
| 2022-03-29 5:14 pm Unchanged |
2022-03-29 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 8,380,265 10.900% |
0 (Unchanged) |
Filing History |
| 2022-03-24 4:30 pm Purchase |
2022-03-14 | 13G | Standard BioTools Inc. LAB |
RA Capital Management, L.P. | 4,651,177 6.000% |
4,651,177 (New Position) |
Filing History |
| 2022-03-07 4:15 pm Purchase |
2022-02-24 | 13G | Standard BioTools Inc. LAB |
North Sound Trading, LP | 4,375,000 5.700% |
4,375,000 (New Position) |
Filing History |
| 2022-02-14 3:46 pm Purchase |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,585,905 9.900% |
49,555 (+0.66%) |
Filing History |